+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Tenofovir"

HIV Drugs Global Market Report 2024 - Product Thumbnail Image

HIV Drugs Global Market Report 2024

  • Report
  • February 2024
  • 175 Pages
  • Global
From
US HIV Infection Drug Market, Dosage, Price, Sales Insight 2021 - 2026 - Product Thumbnail Image

US HIV Infection Drug Market, Dosage, Price, Sales Insight 2021 - 2026

  • Report
  • February 2021
  • 360 Pages
  • United States
From
From
From
From
Stribild Drug Overview 2019 - Product Thumbnail Image

Stribild Drug Overview 2019

  • Report
  • June 2019
  • 16 Pages
  • Global
Isentress (raltegravir; Merck & Co) Drug Overview 2019 - Product Thumbnail Image

Isentress (raltegravir; Merck & Co) Drug Overview 2019

  • Report
  • June 2019
  • 14 Pages
  • Global
From
Loading Indicator

Tenofovir is an antiretroviral drug used to treat HIV/AIDS. It is a nucleotide reverse transcriptase inhibitor (NRTI) that works by blocking the action of the reverse transcriptase enzyme, which is responsible for the replication of HIV. Tenofovir is used in combination with other antiretroviral drugs to treat HIV infection. It is also used to prevent HIV infection in people who are at high risk of infection. Tenofovir is available in both oral and injectable forms. Tenofovir is a widely used antiretroviral drug for the treatment of HIV/AIDS. It is generally well tolerated and has few side effects. It is also effective in reducing the risk of HIV transmission. Tenofovir is available in generic form, which makes it more affordable for people living with HIV/AIDS. Some companies in the Tenofovir market include Gilead Sciences, ViiV Healthcare, Mylan, and Cipla. Show Less Read more